-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pfizer, which has successfully developed the new mRNA vaccine, has raised the price of more than 130 drugs since the beginning of the year, including a 0.22 percent increase in the price of Norpace CR, an anti-arrhythmic drug, and a 5.14 percent increase in the price of Prevnar 13, one of the world's best-selling vaccines.
, which was acquired last year by AbbVie in a deal worth about $63 billion, also raised the price of more than 30 drugs by 5 per cent this year.
, an internationally renowned manufacturer of ophthalmology devices, carried out 39 price increases, ranging from 3.43 percent to 7.9 percent.
also raised the price of 11 drugs this year, as did Eliquis, a blood thinner developed in a joint relationship with Pfizer.
GlaxoSmithKline has also raised the price of 31 drugs and vaccines this year.
, GlaxoSmithKline's vaccine prices rose by more than 5%, such as the Shingrix vaccine for shingrix with shingles, which rose 7%, and the Pediarix vaccine for diphtheria, whooping cough and tejama, which rose by 8.59%.
addition, AstraZeneta, Sanofi, Gilead Sciences and Bayer have raised the prices of more than a dozen drugs this year by less than 10 per cent.
, according to GoodRx, Teva has raised the price of 16 drugs by more than 9 per cent this year, with the biggest price increase so far this year coming from Vifor Pharmaceuticals.
the company raised the price of its famous sucrose iron injection Venofer by 14.58 per cent this year.
as of Sunday, GoodRx had tracked a 4.2 percent increase in the list price of 589 drugs in the U.S. this year, compared with a much higher price increase in the U.S. this year than in the same period in recent years.
3 January 2020, 463 drug prices rose, up from 295 in 2019.
, 2021 figures are already higher than in the past two years and are likely to continue to grow in the future.
January 2020, pharmaceutical companies eventually increased the prices of 619 drugs.
, according to GoodRx, a total of 601 drugs were added in January 2019, an average increase of 5.8 per cent, and the number of drugs priced in January 2018 was 729, an average increase of 7.7 per cent.
In the past few months, U.S. President Donald Trump has passed a series of executive orders in the hope of achieving lasting control over drug prices in the U.S. market, but his most promising "most-favoured-nation" provision, which aims to link drug prices for U.S. health insurance to lower drug prices in overseas markets, has not been implemented.
the Trump administration has achieved relatively limited results over the past few years in controlling routine price increases in the pharmaceutical industry, according to a commentary on the media.